Trade Gilead ^GILD

PensionDanmark Pensionsforsikringsaktieselskab Increases Position in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Markets Daily

Czech National Bank Raises Stock Holdings in Gilead Sciences, Inc. $GILD

NewEdge Advisors LLC Buys 231,715 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Analysts

Assenagon Asset Management S.A. Boosts Stock Holdings in Gilead Sciences, Inc. $GILD

The dynamic spectrum of steatotic liver disease: the global perspective

Canandaigua National Bank & Trust Co. Acquires Shares of 5,547 Gilead Sciences, Inc. $GILD

Canandaigua National Bank & Trust Co. Invests $701,000 in Gilead Sciences, Inc. $GILD - Zolmax

CoreCap Advisors LLC Raises Stake in Gilead Sciences, Inc. $GILD - Markets Daily

Dynamic Advisor Solutions LLC Raises Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences Reports Strong Q2 Sales Growth Amid Losses from Acquisitions, ETPharma

Gilead Sciences (NASDAQ:GILD) Given New $123.00 Price Target at Royal Bank Of Canada

Gilead (GILD) Faces HIV Drug Access Criticism From AIDS Healthcare Foundation

Kymera Reports Narrower Loss In Q2 As Collaboration Revenue Jumps

Top Medical Stocks To Research - August 5th - Stock Observer

Gilead Sciences, Inc. Declares Quarterly Dividend of $0.82 (NASDAQ:GILD)

Needham & Company LLC Reiterates Buy Rating for Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Plans Quarterly Dividend of $0.82 - Stock Observer

Gilead Sciences (NASDAQ:GILD) Announces Quarterly Earnings Results - Stock Observer

Gilead Sciences (NASDAQ:GILD) Receives "Overweight" Rating from Cantor Fitzgerald - Stock Observer

Gilead's Steady Long-Term Growth Prospects in HIV and Expansion in Oncology Support a Wide Moat | Morningstar

Gilead Sciences (NASDAQ:GILD) Issues Earnings Results, Beats Estimates By $0.51 EPS

Gilead Sciences Q2 Earnings Call Highlights

CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock

Gilead Sciences Swings to 2Q Loss on R&D Costs, HIV-Drug Sales Lift Revenue | Morningstar

Gilead Swings To Q2 Loss On Acquisition Charges

Gilead second-quarter sales rise 8%, beating Wall Street estimates

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Expectations By $0.51 EPS - Daily Political

GILD Q2 2026 Earnings Report on 8/3/2026

Could Gilead Sciences (GILD) Have a Major HIV Growth Engine in Yeztugo?

Gilead Sciences (NASDAQ:GILD) Issues FY 2026 Earnings Guidance - Daily Political

Medical Stocks To Follow Now - August 4th - Stock Observer

Trilogy Capital Inc. Purchases 9,777 Shares of Gilead Sciences, Inc. $GILD

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

Lombard Odier Asset Management Europe Ltd Sells 7,604 Shares of Gilead Sciences, Inc. $GILD - Zolmax

CX Institutional Trims Holdings in Gilead Sciences, Inc. $GILD - Zolmax

CX Institutional Has $7.37 Million Stock Holdings in Gilead Sciences, Inc. $GILD

Confluence Investment Management LLC Trims Holdings in Gilead Sciences, Inc. $GILD

Lombard Odier Asset Management Europe Ltd Has $1.73 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For

Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity - Daily Political

Sapient Capital LLC Has $22.68 Million Position in Gilead Sciences, Inc. $GILD

Promising Medical Stocks To Research - August 3rd - Daily Political

Gilead Sciences, Inc. $GILD Shares Sold by Pacer Advisors Inc. - Stock Observer

Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer

Glenmede Trust Co. NA Trims Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to "Hold"

Promising Medical Stocks To Add to Your Watchlist - August 1st - Daily Political

Gilead Sciences, Inc. $GILD Shares Sold by Groupama Asset Managment

Groupe la Francaise Increases Stake in Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences (NASDAQ:GILD) Lowered to "Hold" Rating by Wall Street Zen

2 Large-Cap Stocks for Long-Term Investors and 1 Facing Challenges

Norris Financial Group LLC Makes New Investment in Gilead Sciences, Inc. $GILD

Janus Henderson Group PLC Has $274.92 Million Stake in Gilead Sciences, Inc. $GILD

Do Wall Street Analysts Like Gilead Sciences Stock?

Kentucky Retirement Systems Buys 48,403 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Hamilton Wealth LLC Buys 80,751 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Bank of America Corp DE Cuts Holdings in Gilead Sciences, Inc. $GILD

Caxton Associates LLP Sells 548,559 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Acquired by Arkadios Wealth Advisors

Gilead (GILD) Stock Stays Cheap On Its 130% Five Year Run

Hamilton Wealth LLC Purchases 80,751 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences (GILD) Following Trodelvy Progress And A Fair Value Debate

Oddo BHF Asset Management Sas Purchases 11,575 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management

Barclays Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

FY2027 EPS Estimates for Gilead Sciences Lowered by Analyst - Zolmax

Erste Group Bank Predicts Gilead Sciences FY2027 Earnings

The Manufacturers Life Insurance Company Has $173.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Shares Bought by Waverly Advisors LLC

Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial

Gilead Sciences, Inc. $GILD Position Boosted by Amundi

Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009

GILD: Future Returns Will Depend On HIV Franchise And Oncology Execution

Morgan Stanley says buy these quality stocks. They also pay dividends

Gilead Sciences (GILD) Expected to Post Quarterly Earnings on Monday

Gilead Sciences, Inc. $GILD Shares Bought by KCM Investment Advisors LLC

Quantinno Capital Management LP Buys 117,534 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Empowered Funds LLC Has $27.24 Million Stake in Gilead Sciences, Inc. $GILD - Zolmax

Empowered Funds LLC Increases Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Morgan Stanley Has Lowered Expectations for Gilead Sciences (NASDAQ:GILD) Stock Price

AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus

#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters

Wealth Alliance LLC Sells 4,400 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Orbimed Advisors LLC Buys New Shares in Gilead Sciences, Inc. $GILD

Wealth Alliance LLC Cuts Stake in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead (GILD) Wins Key Europe Backing For Trodelvy In Triple Negative Breast Cancer

Gilead Sciences, Inc. $GILD Shares Sold by Lombard Odier Asset Management Europe Ltd - Daily Political

OMERS ADMINISTRATION Corp Has $162.10 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political

Best Pharmaceutical Stocks To Watch Now - July 25th